The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...
The Food and Drug Administration Jan. 30 announced it approved Journavx (suzetrigine) oral tablets, a first-in-class ...
The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...
The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
The FDA has updated the December recall of some of Cal Yee Farms' products to the highest risk level classification for three ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
Prescription medication injuries are a major concern that call for quick attention and response. The first things you should ...
Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, potentially expanding treatment access for patients.
A major chocolate recall has been upgraded to the highest possible risk level. Last month, Cal Yee Farm LCC issued a recall on its chocolate and yogurt covered products, since they may have contained ...
The FDA has issued a classification for an existing mustard recall for Keith Valley and Red Boy Mustard after the products tested positive for salmonella.